Most Read Articles
13 Jul 2020
Deep vein thrombosis or atrial fibrillation patients with a non-O blood type appear to require higher warfarin doses, a recent study has found.
Jairia Dela Cruz, 22 Jun 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) perform better than warfarin for stroke prevention in Asian patients with nonvalvular atrial fibrillation (AF) and supranormal renal function, according to a study.
Pearl Toh, 2 days ago
The direct oral anticoagulant apixaban may help prevent deaths when given at prophylactic or therapeutic doses in hospitalized COVID-19 patients with elevated D-dimer levels, according to an analysis presented during the ISTH 2020 Congress.
Roshini Claire Anthony, 01 Jul 2020

Adding veliparib to a carboplatin-paclitaxel combination improved progression-free survival (PFS) in patients with BRCA1/2 hormone receptor-positive (HR+) or triple-negative breast cancer (TNBC), subgroup analysis of the phase III BROCADE3* trial showed.

Product Highlight - Saxenda

30 Jun 2020

Active ingredient: 1 ml of solution contains 6 mg of liraglutide. One pre-filled pen contains 18 mg liraglutide in 3 ml
Indications: Saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial
Body Mass Index (BMI) of

  • ≥30 kg/m² (obese), or
  • ≥27 kg/m² to <30 kg/m² (overweight) in the presence of at least one weight-related comorbidity such as dysglycaemia (pre-diabetes or type 2 diabetes mellitus), hypertension, dyslipidaemia or obstructive sleep apnoea.

Dosage & Administration: The starting dose is 0.6 mg daily. The dose should be increased to 3.0 mg daily in increments of 0.6 mg with at least one week interval to improve gastro-intestinal tolerability. Saxenda® is administered once daily at any time, independent of meals, subcutaneously injected in the abdomen, thigh or upper arm, preferably around the same time every day.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
13 Jul 2020
Deep vein thrombosis or atrial fibrillation patients with a non-O blood type appear to require higher warfarin doses, a recent study has found.
Jairia Dela Cruz, 22 Jun 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) perform better than warfarin for stroke prevention in Asian patients with nonvalvular atrial fibrillation (AF) and supranormal renal function, according to a study.
Pearl Toh, 2 days ago
The direct oral anticoagulant apixaban may help prevent deaths when given at prophylactic or therapeutic doses in hospitalized COVID-19 patients with elevated D-dimer levels, according to an analysis presented during the ISTH 2020 Congress.
Roshini Claire Anthony, 01 Jul 2020

Adding veliparib to a carboplatin-paclitaxel combination improved progression-free survival (PFS) in patients with BRCA1/2 hormone receptor-positive (HR+) or triple-negative breast cancer (TNBC), subgroup analysis of the phase III BROCADE3* trial showed.